Furthermore, a study has revealed that overexpression of both EGFR and IGF-1R was observed in 24.8% of 125 surgical NSCLC patients, and high co-expression of EGFR and IGF-1R was a significant prognostic factor of worse disease-free survival (DFS) [29]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.